More Clarity Needed on MedAssets (NASDAQ:MDAS) Says Jefferies

Jefferies says they like the positioning of MedAssets (NASDAQ:MDAS)in the healthcare sector, but more clarity is needed for them to escape being range bound.

"We continue to believe that MDAS is well positioned in the healthcare market with a focus on cost-savings and revenue cycle; however, with moving parts such as Broadlane and caution on revenue cycle transformation deals, we believe that the stock is range bound until more clarity emerges," said Jefferies.

EPS estimates for full year 2011 were raised from $1.03 to $1.16.

Overall, Jefferies believes MedAssets, which closed Wednesday at $19.33, gaining $0.78. or 4.23 percent, will have a better year in 2011 than they did in 2010. Jefferies has a price target on them of $22, raising it from $20.